SEARCH

SEARCH BY CITATION

References

  • 1
    Glise H, Hallerback B, Wiklund I. Quality of life: a reflection of symptoms and concerns. Scand J Gastroenterol 1996; 31(Suppl. 221): 14 17.
  • 2
    Guyatt GH. Measuring quality of life: a review of means of measurement in clinical trials of new medicines. Pharm Med 1987; 2: 49 60.
  • 3
    Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622 9.
  • 4
    Guyatt GH & Jaaeschke R. Measurement in clinical trials; choosing the appropriate approach. In: Spilker B, ed. Assessment in Clinical Trials. New York, Raven Press, 1990: 37.
  • 5
    Guyatt G, Deyo RA, Charlson M, Levine MN, Mitchell A. Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol 1989; 42: 403 8.
  • 6
    Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci 1995; 40: 584 9.
  • 7
    Dimenäs E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995; 30: 1046 52.
  • 8
    Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ. Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc 1998; 47: 449 54.
  • 9
    Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. J Am Med Assoc 1989; 262: 907 13.
  • 10
    Veldhuyzen van Zanten SJO, Cleary C, Talley NJ, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996; 91: 660 73.
  • 11
    Hahn BA, Kirchdoerfer LJ, Fullertson Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther 1997; 11: 533 59.
  • 12
    Whitehead WE, Burnett CK, Cook EW, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 1996; 41: 2248 53.
  • 13
    Talley NJ, Lambert JR, Howell S, Xia HH-X, Lin SK, Agreus L. An evaluation of whole blood testing for Helicobacter pylori in the general practice. Aliment Pharmacol Ther 1998; 12: 641 5.
  • 14
    Talley NJ, Boyce P, Owen BK, Newman P, Paterson K. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australia. Aust NZ J Med 1995; 40: 1345 50.
  • 15
    Talley NJ, Phillips SF, Melton LJ, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671 4.
  • 16
    Ware JE & Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30: 473 83.
  • 17
    Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297 334.
  • 18
    Jones RH. Clinical economics review: gastrointestinal disease in primary care. Aliment Pharmacol Ther 1996; 10: 233 9.
  • 19
    De Bruin AF, Diederiks JP, De Witte LP, Stevens FC, Philipsen H. Assessing the responsiveness of a functional status measure: the Sickness Impact Profile versus the SIP68. J Clin Epidemiol 1997; 50: 529 40.
  • 20
    El-Omar EM, Banerjee S, Wirz A, McColl KE. The Glasgow dyspepsia severity score—a tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol 1996; 8: 967 71.
  • 21
    Jonsson BH, Theorell T, Gotthard R. Symptoms and personality in patients with chronic functional dyspepsia. J Psychosom Res 1995; 39: 93 102.
  • 22
    Haug TT, Wilhelmsen I, Berstad A, Ursin H. Life events and stress in patients with functional dyspepsia compared with patients with duodenal ulcer and healthy controls. Scand J Gastroenterol 1995; 30: 524 30.
  • 23
    Lindell GH, Celebioglu F, Graffner HO. Non-ulcer dyspepsia in the long-term perspective. Eur J Gastroenterol Hepatol 1995; 7: 829 33.
  • 24
    Kurata JH, Nogawa AN, Chen YK, Parker CE. Dyspepsia in primary care: perceived causes, reasons for improvement, and satisfaction with care. J Fam Pract 1997; 44: 281 8.
  • 25
    Cuperus P, Keeling PW, Gibney MJ. Eating patterns in functional dyspepsia: a case control study. Eur J Clin Nutr 1996; 50: 520 3.
  • 26
    Lond E, Varmann P, Elshtein N, et al. Dyspepsia in rural residents of Estonia. Life-style factors, psychoemotional disorders, and familial history of gastrointestinal diseases. Scand J Gastroenterol 1995; 30: 826 8.
  • 27
    Talley NJ & Piper DW. Comparison of the clinical features and illness behaviour of patients presenting with dyspepsia of unknown cause (essential dyspepsia) and organic disease. Aust NZ J Med 1986; 16: 352 9.
  • 28
    Mertz H, Fass R, Kodner A, Yan-Go F, Fullerton S, Mayer EA. Effect of amitriptyline on symptoms, sleep and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998; 93: 160 5.
    Direct Link:
  • 29
    David D, Mertz H, Fefer L, et al. Sleep and duodenal motor activity in patients with severe non-ulcer dyspepsia. Gut 1994; 35: 916 25.